AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
Mar 5, 2013
31971_dirs_2013-03-05_51a15134-4926-4e40-8f6f-b83881992f68.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-03-04
Reporting Person: ABRAHAM WILLIAM (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-03-04 | Common Stock | M | 10000 | $17.74 | Acquired | 27935 | Direct |
| 2013-03-04 | Common Stock | S | 10000 | $30.7146 | Disposed | 17935 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-03-04 | Options To Purchase Common Stock | $17.74 | M | 10000 | Disposed | 2013-05-20 | Common Stock (10000) | Direct |
Footnotes
F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: 5 year vesting schedule, 20% vesting each year starting 5/20/2004
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7